Clinical trial recovery from COVID-19 disruption
Nat Rev Drug Discov
.
2020 Oct;19(10):662-663.
doi: 10.1038/d41573-020-00150-9.
Authors
John Z Xue
,
Katarzyna Smietana
,
Pawel Poda
,
Kevin Webster
,
Guang Yang
,
Gaurav Agrawal
PMID:
32913212
DOI:
10.1038/d41573-020-00150-9
No abstract available
Publication types
News
Research Support, Non-U.S. Gov't
MeSH terms
COVID-19
Clinical Trials as Topic* / statistics & numerical data
Coronavirus Infections*
Humans
Pandemics*
Pneumonia, Viral*